Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy.

Authors :: Griffin I
Woodworth KR
Galang RR
Burkel VK
Neelam V
Siebman S
Barton J
Manning SE
Aveni K
Longcore ND
Harvey EM
Ngo V
Mbotha D
Chicchelly S
Lush M
Eckert V
Dzimira P
Sokale A
Valencia-Prado M
Azziz-Baumgartner E
MacNeil A
Gilboa SM
Tong VT
Source :: Emerging infectious diseases [Emerg Infect Dis] 2022 Apr; Vol. 28 (4), pp. 873-876. Date of Electronic Publication: 2022 Feb 25.
Publication Year :: 2022
Abstract: The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 142 (2.2%) had positive RNA tests >90 days and up to 416 days after infection.

Subjects :: Female
Humans
Laboratories
Pregnancy
RNA, Viral
SARS-CoV-2 genetics
Serologic Tests
United States
COVID-19 diagnosis
Pregnancy Complications, Infectious epidemiology

Full Text Access

Tools